Related Experiment Video
Updated: May 16, 2026
06:06
Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
Published on: July 22, 2021
Osteoarthritis: research update and clinical applications
Annamaria Iagnocco1, Esperanza Naredo
1Rheumatology Unit, Sapienza Università di Roma, Rome, Italy.
Rheumatology (Oxford, England)
|December 12, 2012
Summary
Musculoskeletal ultrasonography (MSUS) provides a comprehensive joint assessment for osteoarthritis (OA), improving diagnosis and management. This imaging technique enhances detection of joint abnormalities and guides therapeutic injections.
Area of Science:
- Orthopedics
- Radiology
- Rheumatology
Background:
- Musculoskeletal ultrasonography (MSUS) is a valuable tool for assessing joints affected by osteoarthritis (OA).
- It can be performed chairside during patient consultations, offering high patient acceptability.
- Immediate correlation of imaging findings with clinical data aids in OA diagnosis and management.
Purpose of the Study:
- To outline the current clinical and research applications of MSUS in osteoarthritis.
- To highlight the advantages of MSUS over traditional methods like clinical examination and radiography.
Main Methods:
- Utilizing MSUS for the detection of articular cartilage damage, bone changes, joint inflammation, and soft tissue lesions in OA joints.
- Comparing the sensitivity of MSUS with clinical examination and plain radiography for specific OA-related findings.
Main Results:
- MSUS demonstrates high sensitivity in detecting synovitis and bone surface abnormalities, surpassing clinical examination and radiography respectively.
- The technique is effective in guiding accurate and safe diagnostic or therapeutic injections into OA joints.
Conclusions:
- MSUS is a versatile imaging modality with significant applications in both the clinical practice and research of osteoarthritis.
- Its ability to provide detailed joint assessment and guide interventions makes it an indispensable tool for OA patient care.
Related Concept Videos
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:22Connective Tissue Cell Types
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:23Degenerative Disc Disease ll: Pathophysiology
The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...